Form 4 for PRME Prime Medicine, Inc.
Accepted 2025-05-22 00:00:00 ET · period of report 2025-05-21 · accession 0001894562-25-000028 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-05-22 | 2025-05-21 | PRME | LEE ANN L. | Chief Technical Off | P - Purchase | $1.13 | +100.0K | 100.0K | New | +$113.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-05-21 | P | A | 100,000 | $1.13 | 100,000 | D | — | — |